Difference between revisions of "Part:BBa K1202106"
| Line 1: | Line 1: | ||
| − | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K1202106 short</partinfo> | <partinfo>BBa_K1202106 short</partinfo> | ||
| − | + | HA2 peptide sequence is demonstrated that, with the combination of TAT, the cell penetrating activity increases considerably. We added HA2 in our TAT-Apoptin system to empower the yield of cancer killing mechanism. | |
| − | Apoptin | + | |
| − | + | Apoptin is a novel prospective cancer drug which induces programmed cell death (apoptosis) phase of normal cell life cycle in cancer cells, selectively. The exact mechanism of apoptin is not understood, yet. But, the efficiency and results of the function are researched and pose promising hopeful results for efficient cancer therapy. | |
| − | + | ||
Latest revision as of 00:35, 5 October 2013
TAT-HA2-Apoptin: Cancer killing peptide
HA2 peptide sequence is demonstrated that, with the combination of TAT, the cell penetrating activity increases considerably. We added HA2 in our TAT-Apoptin system to empower the yield of cancer killing mechanism.
Apoptin is a novel prospective cancer drug which induces programmed cell death (apoptosis) phase of normal cell life cycle in cancer cells, selectively. The exact mechanism of apoptin is not understood, yet. But, the efficiency and results of the function are researched and pose promising hopeful results for efficient cancer therapy.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 7
Illegal NheI site found at 30 - 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 462
- 1000COMPATIBLE WITH RFC[1000]